Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Travis, E. Brambilla, H. Müller-hermelink (2004)
Pathology and genetics of tumours of the lung , pleura, thymus and heart
W. Travis, E. Brambilla, M. Noguchi, A. Nicholson, K. Geisinger, Y. Yatabe, D. Beer, C. Powell, Gregory Riely, P. Schil, K. Garg, J. Austin, H. Asamura, V. Rusch, F. Hirsch, G. Scagliotti, T. Mitsudomi, R. Huber, Y. Ishikawa, J. Jett, M. Sanchez-Cespedes, J. Sculier, Takashi Takahashi, M. Tsuboi, J. Vansteenkiste, I. Wistuba, Pan‐Chyr Yang, D. Aberle, C. Brambilla, D. Flieder, W. Franklin, A. Gazdar, M. Gould, P. Hasleton, D. Henderson, B. Johnson, David Johnson, K. Kerr, K. Kuriyama, J. Lee, V. Miller, I. Petersen, V. Roggli, R. Rosell, N. Saijo, E. Thunnissen, M. Tsao, David Yankelewitz (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung AdenocarcinomaJournal of Thoracic Oncology, 6
S. Ou, J. Zell (2009)
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer HistologiesJournal of Thoracic Oncology, 4
M. Vazquez, D. Carter, E. Brambilla, A. Gazdar, M. Noguchi, W. Travis, Yao Huang, Lijuan Zhang, R. Yip, D. Yankelevitz, C. Henschke (2009)
Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications.Lung cancer, 64 2
Prognostic significance of the proposed IASLC/ATS/ERS revised classification of lung adenocarcinoma in 514 stage I lung adenocarcinomas
C. Bryant, Daniel Albertus, Sinae Kim, Guoan Chen, C. Brambilla, M. Guedj, Chinatsu Arima, W. Travis, Y. Yatabe, Takashi Takahashi, E. Brambilla, D. Beer (2010)
Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation StudyPLoS ONE, 5
N. Girard, C. Deshpande, C. Lau, D. Finley, V. Rusch, W. Pao, W. Travis (2009)
Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From MetastasesThe American Journal of Surgical Pathology, 33
G. Pelosi, A. Sonzogni, G. Veronesi, E. Camilli, P. Maisonneuve, L. Spaggiari, M. Manzotti, M. Masullo, G. Taliento, C. Fumagalli, M. Bellomi, W. Travis, M. Kadivar, G. Viale (2008)
Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study.Lung cancer, 62 2
F. Hirsch, M. Wynes, D. Gandara, P. Bunn (2010)
The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung CancerClinical Cancer Research, 16
W. Travis, T. Colby, B. Corrin, Y. Shimosato, E. Brambilla (1999)
Histological Typing of Lung and Pleural Tumours
G. Sica, A. Yoshizawa, C. Sima, C. Azzoli, R. Downey, V. Rusch, W. Travis, A. Moreira (2010)
A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I TumorsThe American Journal of Surgical Pathology, 34
J. Subramanian, D. Morgensztern, B. Goodgame, M. Baggstrom, F. Gao, J. Piccirillo, R. Govindan (2010)
Distinctive Characteristics of Non-small Cell Lung Cancer (NSCLC) in the Young: A Surveillance, Epidemiology, and End Results (SEER) AnalysisJournal of Thoracic Oncology, 5
D. Carter, M. Vazquez, D. Flieder, E. Brambilla, A. Gazdar, M. Noguchi, W. Travis, A. Kramer, R. Yip, D. Yankelevitz, C. Henschke (2007)
Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening.Lung cancer, 56 2
Y. Anami, T. Iijima, Kenji Suzuki, J. Yokota, Y. Minami, Hiromi Kobayashi, K. Satomi, Y. Nakazato, Masafumi Okada, M. Noguchi (2009)
Bronchioloalveolar Carcinoma (Lepidic Growth) Component Is a More Useful Prognostic Factor than Lymph Node MetastasisJournal of Thoracic Oncology, 4
B. Smith (2008)
Therapeutic pathology: time to move beyond diagnostics.Human pathology, 39 12
A. Jemal, R. Siegel, Jiaquan Xu, Elizabeth Ward (2010)
Cancer Statistics, 2010CA: A Cancer Journal for Clinicians, 60
A. Yoshizawa, N. Motoi, Gregory Riely, C. Sima, W. Gerald, M. Kris, Bernard Park, V. Rusch, W. Travis (2011)
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I casesModern Pathology, 24
(2011)
IASCL/ATS/ERS International multidisciplinary classification of lung adenocarcinoma
W. Travis, N. Rekhtman, G. Riley, K. Geisinger, H. Asamura, E. Brambilla, K. Garg, F. Hirsch, M. Noguchi, C. Powell, V. Rusch, G. Scagliotti, Y. Yatabe (2010)
Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 5 4
M. Noguchi (2010)
Stepwise progression of pulmonary adenocarcinoma—clinical and molecular implicationsCancer and Metastasis Reviews, 29
D. Finley, A. Yoshizawa, W. Travis, Qin Zhou, V. Seshan, M. Bains, R. Flores, N. Rizk, V. Rusch, Bernard Park (2007)
Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung CancersJournal of Thoracic Oncology, 5
Y. Sakao, H. Miyamoto, M. Sakuraba, T. Oh, K. Shiomi, Satoshi Sonobe, H. Izumi (2007)
Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.The Annals of thoracic surgery, 83 1
N. Dubrawsky (1989)
Cancer statisticsCA: A Cancer Journal for Clinicians, 39
N. Motoi, J. Szőke, Gregory Riely, V. Seshan, M. Kris, V. Rusch, W. Gerald, W. Travis (2008)
Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression AnalysisThe American Journal of Surgical Pathology, 32
EDITORIAL The New Taxonomy of Lung Adenocarcinoma Stemming from a Multidisciplinary Integrated Approach Novel Pathology Concepts and Perspectives Giuseppe Pelosi, MD, MIAC ung cancer is the leading cause of morbidity and death all over the world and a Lsignificant burden on healthcare resources of most countries. Among the diverse histologic subtypes, adenocarcinoma (AD) is the most common type of lung cancer in both males and females in most countries, even in young people, and in tumors detected 3,4 in screening low-dose computed tomography programs. The characteristic mixture of multiple subtypes has been a major source of inconsistency in subclassification in the past, hence the axiom, the more tumor categories, the more difficulties in the diagnosis. Therefore, new diagnostic criteria and uniform and consistent terminology are needed to improve accuracy and permit correlations between pathology and multiple patient char- acteristics including clinical features, tumor staging, molecular signatures, prognostic and predictive markers, and imaging data. Morphology still remains an agreed-on gold standard for AD, but a global rethinking of its histopathologic basis by exploiting an integrated multidisciplinary approach could really improve our diagnostic, prognostic, and predictive capabilities. The issue of accurate subtyping of poorly differentiated tumors and limited diagnostic material for
Journal of Thoracic Oncology – Wolters Kluwer Health
Published: Feb 1, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.